IPO Timeline
Open Date18-Jan-24
Close Date23-Jan-24
Allotment24-Jan-24
Refund Initiation25-Jan-24
Demat Credit25-Jan-24
UPI Mandate Deadline23-Jan-24
Listing Date29-Jan-24
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| NII (HNI) | — | 932,400 (47%) | — | ₹932 Cr |
| Retail | — | 932,400 (47%) | — | ₹932 Cr |
| Market Maker | — | 99,600 (5%) | — | ₹10 Cr |
| Σ Total | — | 1,964,400 (100%) | — | ₹19,644 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Issue Price / Price Band₹100
Face Value₹10
Lot Size1,200 shares
Issue Size1,964,400 shares (aggregating up to ₹20 Cr)
Issue TypeFixed Price IPO
Listing ExchangeBSE SME
Sale TypeFresh Capital
Script Code—
Net Offer to Public1,864,800 shares (aggregating up to ₹19 Cr)
Amount In₹ Lakhs
Stock Price History · BSE
—
H—
L—
O—
Yahoo Finance · Live
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,200 | ₹120,000 |
| Retail (Max) | 13 | 15,600 | ₹1,560,000 |
| S-HNI (Min) | 14 | 16,800 | ₹1,680,000 |
| B-HNI (Min) | 67 | 80,400 | ₹8,040,000 |
Retail1 lot(s)1,200 shares₹120,000
S-HNI2 lot(s)2,400 shares₹240,000
Financial Statements Amount in ₹ Lakhs
| Metric | 30 Sep 2023 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|
| Revenue | 1,251 | 1,935 | 1,202 |
| Profit After Tax | 201 | 297 | 114 |
| Net Worth | 1,187 | 987 | 190 |
| Total Assets | 4,410 | 3,956 | 2,220 |
| Reserves & Surplus | 647 | 446 | 144 |
| Total Borrowing | 2,500 | 2,345 | 1,729 |
Valuation & Key Ratios
ROE50%
ROCE14%
RONW30%
PAT Margin—
EBITDA Margin—
Debt/Equity—
P/BV4
Pre EPS₹5
Post EPS₹5
Pre P/E18
Post P/E18
Grey Market Premium (GMP)
—
Current GMP
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- Funding capital expenditure towards the installation of plant and machinery for new & existing laboratories and expansion of laboratories; –
- Repayment of unsecured loans to Promoter; –
- Funding of working capital requirements; and –
- General corporate purposes. –
Company Overview
Founded in 2018, Qualitek Labs Limited provides testing, inspection, homologation, certification, and consulting services.
The company's laboratory services include:
- Automotive Testing
- Defence Product Testing
- Metals & Metallurgy Testing
- Mineral Testing
- Environment & Water Testing
- Food and Agriculture Testing
- Pharma & Healthcare
They collaborate with industries such as automotive, defence, metals and metallurgy, environment and water, minerals, food and agriculture, and pharma and healthcare.
The company has two testing laboratories in Pune and Bhubaneshwar.
As of Jan 2024, the company has a total of 144 employees.
Company Information
Address73, National Park Lajpat Nagar- IV New Delhi, South Delhi - 110024 New Delhi, New Delhi
Phone+011-41729056
Emailinfo@qualiteklab.com
Websitehttp://www.qualiteklab.com/